FDA
-
-
-
-
-
-
-
MediPharm Labs Positioned for Unique Opportunities on Possible Rescheduling of Cannabis in the United States
-
-
-
-
-
-
-
MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder
-
-
-
-
-
-
-
MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results
-
-
-
-
-
-
-
MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority
-
-
-
-
-
-
-
MediPharm Labs Makes First Delivery of Cannabis Clinical Trial Material to US Research Partner and Provides Update on US FDA Status
-
-
-
-
-
-
-
MediPharm Labs Appoints New Chief Executive Officer
-
-
-
-
-
-
322,979 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

